You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 2, 2025

Drug Price Trends for MS CONTIN


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for MS CONTIN

Average Pharmacy Cost for MS CONTIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
MS CONTIN ER 30 MG TABLET 42858-0631-01 8.32796 EACH 2024-12-18
MS CONTIN ER 30 MG TABLET 42858-0631-01 8.32796 EACH 2024-11-20
MS CONTIN ER 15 MG TABLET 42858-0515-01 4.40368 EACH 2024-06-03
MS CONTIN ER 30 MG TABLET 42858-0631-01 8.38027 EACH 2024-06-03
MS CONTIN ER 15 MG TABLET 42858-0515-01 4.04004 EACH 2024-05-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for MS CONTIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
MS CONTIN 60MG CR TAB Rhodes Pharmaceuticals L.P. 42858-0760-01 100 1568.76 15.68760 EACH 2024-01-01 - 2026-02-14 FSS
MS CONTIN 200MG CR TAB Rhodes Pharmaceuticals L.P. 42858-0900-01 100 2482.09 24.82090 EACH 2023-01-01 - 2026-02-14 Big4
MS CONTIN 15MG CR TAB Rhodes Pharmaceuticals L.P. 42858-0515-01 100 246.89 2.46890 EACH 2023-01-01 - 2026-02-14 Big4
MS CONTIN 60MG CR TAB Rhodes Pharmaceuticals L.P. 42858-0760-01 100 1568.76 15.68760 EACH 2021-02-15 - 2026-02-14 FSS
MS CONTIN 100MG CR TAB Rhodes Pharmaceuticals L.P. 42858-0799-01 100 1355.32 13.55320 EACH 2024-01-01 - 2026-02-14 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

MS CONTIN Market Analysis and Financial Projection

Market Analysis and Price Projections for MS CONTIN

Overview of MS CONTIN

MS CONTIN, a controlled-release formulation of morphine sulfate, is a potent opioid analgesic used for the management of severe and persistent pain that requires long-term opioid treatment. It is indicated for patients for whom alternative treatment options are inadequate, and it is not intended for as-needed (prn) use[1][5].

Market Size and Growth

The global morphine market, which includes MS CONTIN, is projected to experience significant growth. As of 2023, the global morphine market was valued at USD 22.46 billion and is expected to reach USD 34.87 billion by 2033, growing at a Compound Annual Growth Rate (CAGR) of 4.50% during this period[3].

Regional Market Analysis

  • North America: This region is expected to hold the largest share of the global morphine market due to the presence of significant market players, supportive government regulations, and a high prevalence of chronic pain conditions such as musculoskeletal disorders and cancer-related pain. The United States, with its advanced healthcare system and large patient population, is a key driver in this region[3].
  • Asia Pacific: This region is predicted to grow at the fastest pace due to rising healthcare costs, developing healthcare infrastructure, and the expansion of healthcare facilities in countries like China and India. The large and growing population in this region also contributes to the increasing demand for morphine and other pain management options[3].

Pricing and Cost Considerations

The cost of MS CONTIN can vary significantly based on the dosage and the pharmacy.

  • Dosage and Pricing:
    • The cost for MS CONTIN oral tablets, extended release, ranges from approximately $493 for 100 tablets of the 15 mg dose to $4,867 for 100 tablets of the 200 mg dose[2].
    • Here is a breakdown of the prices:
    • 15 mg/8 to 12 hr: $492.68 for 100 tablets
    • 30 mg/8 to 12 hr: $927.65 for 100 tablets
    • 60 mg/8 to 12 hr: $1,801.07 for 100 tablets
    • 100 mg/8 to 12 hr: $2,662.03 for 100 tablets
    • 200 mg/8 to 12 hr: $4,867.31 for 100 tablets[2].

Generic and Discount Options

  • Generic Version: Although a generic version of MS CONTIN has been approved by the FDA, it is not commercially available or its pricing information is not readily available[2].
  • Discounts and Coupons: Patients can use discount cards, copay cards, and other savings programs to reduce the cost of MS CONTIN. For example, the Drugs.com Discount Card can save up to 80% or more off the cost of prescription medicines[2].

Competitive Landscape

The morphine market, including MS CONTIN, is competitive with various formulations available such as oral tablets, injections, and capsules. The oral tablets segment, which includes MS CONTIN, is anticipated to hold the greatest share of the global morphine market due to its convenience and controlled-release formula that provides longer-lasting pain relief[3].

Regulatory and Safety Considerations

The use of MS CONTIN is subject to strict regulatory guidelines due to the risks of addiction, abuse, and misuse associated with opioids. Healthcare professionals must be knowledgeable about the use of extended-release/long-acting opioids and how to mitigate the associated risks. Patients must be carefully selected and monitored, especially when converting from other opioids or when using CNS depressants concomitantly[1][5].

Key Takeaways

  • Market Growth: The global morphine market, including MS CONTIN, is expected to grow significantly by 2033.
  • Regional Dominance: North America is expected to hold the largest share, while the Asia Pacific region will experience the fastest growth.
  • Pricing: The cost of MS CONTIN varies widely based on dosage, with significant discounts available through various programs.
  • Regulatory Considerations: Strict guidelines govern the use of MS CONTIN due to opioid-related risks.

FAQs

Q: What is MS CONTIN used for? A: MS CONTIN is used for the management of severe and persistent pain that requires daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate[1][5].

Q: How much does MS CONTIN cost? A: The cost of MS CONTIN varies by dosage, ranging from approximately $493 for 100 tablets of the 15 mg dose to $4,867 for 100 tablets of the 200 mg dose[2].

Q: Is there a generic version of MS CONTIN available? A: Although a generic version of MS CONTIN has been approved by the FDA, it is not commercially available or its pricing information is not readily available[2].

Q: What are the risks associated with using MS CONTIN? A: MS CONTIN carries risks of addiction, abuse, and misuse, as well as greater risks of overdose and death with extended-release opioid formulations. It should be used with caution, especially when combined with CNS depressants[1][5].

Q: How is MS CONTIN typically dosed? A: MS CONTIN is typically initiated at a dose of 15 mg orally every 8 or 12 hours. Higher doses are reserved for patients who are opioid-tolerant and for whom lower doses are insufficiently effective[1][5].

Sources

  1. MS Contin - accessdata.fda.gov
  2. MS Contin Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com
  3. Global Morphine Market Size To Worth USD 34.87 Billion By 2033 - GlobeNewswire
  4. Abuse-Deterrent Opioids – Evidence Evaluation & Labeling - mass.gov
  5. MS-Contin (Morphine Sulfate Controlled-Release) - RxList

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.